INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 114 filers reported holding INTERSECT ENT INC in Q3 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $2,750,000 | +1027.0% | 202,960 | +884.4% | 0.04% | +146.7% |
Q1 2020 | $244,000 | -63.0% | 20,617 | -22.2% | 0.02% | -6.2% |
Q4 2019 | $660,000 | -17.6% | 26,487 | -43.8% | 0.02% | -33.3% |
Q3 2019 | $801,000 | -66.5% | 47,100 | -55.1% | 0.02% | -71.8% |
Q2 2019 | $2,390,000 | – | 105,000 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |